Insider Trading & Ownership of Pablo G. Legorreta

Location
New York, NY
Summary
The estimated net worth of Pablo G. Legorreta is at least $2,981,352,207 dollars as of 07 Nov 2025. Pablo G. Legorreta is the CEO, Chairman of the Board, Director of Royalty Pharma plc and owns shares of Royalty Pharma plc (RPRX) stock worth about $2.59B. Pablo G. Legorreta is the Director, 10%+ Owner of PROKIDNEY CORP. and owns shares of PROKIDNEY CORP. (PROK) stock worth about $396.23M. Pablo G. Legorreta is the Director, 10%+ Owner of Epizyme, Inc. and owns shares of Epizyme, Inc. stock worth about $23K.
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for Pablo G. Legorreta
All Insider Reports
All Insider Reports

Notify me when Pablo G. Legorreta files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Pablo G. Legorreta

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RPRX Royalty Pharma plc CEO, Chairman of the Board, Director $2,585,100,366 05 Nov 2025
PROK PROKIDNEY CORP. Director, 10%+ Owner $396,228,878 03 Jun 2025
EPZM Epizyme, Inc. Director, 10%+ Owner $22,963 12 Aug 2022

Insider Transactions Reported by Pablo G. Legorreta:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.